HIGHLIGHTS
- who: Jielu Cao and colleagues from the Zhejiang Chinese Medical University, Hangzhou, China have published the article: Aberrant Expression TFR1/CD71 in Gastric Cancer Identifies a Novel Potential Prognostic Marker and Therapeutic Target, in the Journal: Evidence-Based Complementary and Alternative Medicine of 30/08/2022
- what: The authors aimed to evaluate the expression level of TFR1 in GC patients and analyze its impact on the progression and prognosis of GC.
- future: The development of nanoscale TFR1-targeting drugs also provides a new direction for the development of TFR1-specific inhibitors in the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.